These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26491017)

  • 21. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
    Tavor S; Eisenbach M; Jacob-Hirsch J; Golan T; Petit I; Benzion K; Kay S; Baron S; Amariglio N; Deutsch V; Naparstek E; Rechavi G
    Leukemia; 2008 Dec; 22(12):2151-5158. PubMed ID: 18769446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.
    Schroeder TM; Nair AK; Staggs R; Lamblin AF; Westendorf JJ
    BMC Genomics; 2007 Oct; 8():362. PubMed ID: 17925016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.
    Mandawat A; Fiskus W; Buckley KM; Robbins K; Rao R; Balusu R; Navenot JM; Wang ZX; Ustun C; Chong DG; Atadja P; Fujii N; Peiper SC; Bhalla K
    Blood; 2010 Dec; 116(24):5306-15. PubMed ID: 20810927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
    Peled A; Tavor S
    Theranostics; 2013; 3(1):34-9. PubMed ID: 23382784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.
    Zeng Z; Samudio IJ; Munsell M; An J; Huang Z; Estey E; Andreeff M; Konopleva M
    Mol Cancer Ther; 2006 Dec; 5(12):3113-21. PubMed ID: 17172414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
    Zhang Y; Patel S; Abdelouahab H; Wittner M; Willekens C; Shen S; Betems A; Joulin V; Opolon P; Bawa O; Pasquier F; Ito M; Fujii N; Gonin P; Solary E; Vainchenker W; Coppo P; De Botton S; Louache F
    Cell Death Dis; 2012 Oct; 3(10):e396. PubMed ID: 23034331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
    Dai Y; Guzman ML; Chen S; Wang L; Yeung SK; Pei XY; Dent P; Jordan CT; Grant S
    Br J Haematol; 2010 Oct; 151(1):70-83. PubMed ID: 20701602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
    Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
    Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.
    Ramakrishnan R; Peña-Martínez P; Agarwal P; Rodriguez-Zabala M; Chapellier M; Högberg C; Eriksson M; Yudovich D; Shah M; Ehinger M; Nilsson B; Larsson J; Hagström-Andersson A; Ebert BL; Bhatia R; Järås M
    Cell Rep; 2020 May; 31(8):107684. PubMed ID: 32460032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of SDF-1/CXCR4 signal pathway blockade by AMD3100 on the adhesion of leukemia cells to osteoblast niche and the drug resistance of leukemia cells].
    Shen Z; Zeng D; Zou Z; Zhu L; Ma Y; Zhang X; Zhang C; Li J; Kong P
    Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):413-7. PubMed ID: 26031530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
    Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
    Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis.
    Liu L; Alonso V; Guo L; Tourkova I; Henderson SE; Almarza AJ; Friedman PA; Blair HC
    J Biol Chem; 2012 Dec; 287(52):43312-21. PubMed ID: 23109343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
    Abraham M; Klein S; Bulvik B; Wald H; Weiss ID; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Avigdor A; Benjamini O; Nagler A; Pereg Y; Tavor S; Peled A
    Leukemia; 2017 Nov; 31(11):2336-2346. PubMed ID: 28280274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport.
    Zhang Q; Xiao K; Paredes JM; Mamonova T; Sneddon WB; Liu H; Wang D; Li S; McGarvey JC; Uehling D; Al-Awar R; Joseph B; Jean-Alphonse F; Orte A; Friedman PA
    J Biol Chem; 2019 Mar; 294(12):4546-4571. PubMed ID: 30696771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.